Levy Adam Scott

Mineralys Therapeutics, Inc. ยท CFO and Secretary

Levy Adam Scott is listed in public filings as officer: CFO and Secretary. This Levy Adam Scott insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Mineralys Therapeutics, Inc. (MLYS). Investors use Levy Adam Scott's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Mineralys Therapeutics, Inc.MLYS$1.5M53.3k sharesGrant / ExerciseFeb 19, 2026$1.5M53.3k shares$28.06--
Mineralys Therapeutics, Inc.MLYS--48.5k sharesGrant / ExerciseFeb 19, 2026Disclosure amount unavailable39.9k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Mineralys Therapeutics, Inc.MLYS$278k8.6k sharesSellJan 12, 2026$345.7K10.8k shares$32.14--
Mineralys Therapeutics, Inc.MLYS$2.4M52.1k sharesSellNov 11, 2025$1.8M38.9k shares$45.93--
Mineralys Therapeutics, Inc.MLYS$909k19.4k sharesSellNov 11, 2025$1.5M32.7k shares$46.88--
Mineralys Therapeutics, Inc.MLYS$1.3M91.6k sharesGrant / ExerciseNov 11, 2025$628.1K44.1k shares$14.25--
Mineralys Therapeutics, Inc.MLYS$331k20.7k sharesGrant / ExerciseNov 11, 2025$550.6K34.4k shares$16.00--
Mineralys Therapeutics, Inc.MLYS$4.7M112.1k sharesSellNov 11, 2025$539.5K13k shares$41.65--
Mineralys Therapeutics, Inc.MLYS$5.3M126.6k sharesSellNov 11, 2025$472.9K11.3k shares$41.87--
Mineralys Therapeutics, Inc.MLYS$4.1M91k sharesSellNov 11, 2025$382.0K8.5k shares$45.18--
Mineralys Therapeutics, Inc.MLYS$4.4M103.6k sharesSellNov 11, 2025$359.3K8.5k shares$42.34--
Mineralys Therapeutics, Inc.MLYS$549k53.8k sharesGrant / ExerciseNov 11, 2025$209.6K20.5k shares$10.20--
Mineralys Therapeutics, Inc.MLYS$4.3M99.5k sharesSellNov 11, 2025$180.2K4.1k shares$43.50--
Mineralys Therapeutics, Inc.MLYS$75k4.9k sharesGrant / ExerciseNov 11, 2025$102.1K6.6k shares$15.44--
Mineralys Therapeutics, Inc.MLYS$5.3M125k sharesSellNov 11, 2025$66.6K1.6k shares$42.68--
Mineralys Therapeutics, Inc.MLYS$5.8M137.9k sharesSellNov 11, 2025$42.6K1k shares$42.00--
Mineralys Therapeutics, Inc.MLYS$5.0M120.3k sharesSellOct 13, 2025$308.7K7.4k shares$41.90--
Mineralys Therapeutics, Inc.MLYS$4.9M116.9k sharesSellOct 13, 2025$143.3K3.4k shares$42.26--
Mineralys Therapeutics, Inc.MLYS$2.1M141.4k sharesSellJul 30, 2025$757.2K51.5k shares$14.70--
Mineralys Therapeutics, Inc.MLYS$2.0M132.9k sharesSellJul 30, 2025$127.2K8.4k shares$15.10--
Mineralys Therapeutics, Inc.MLYS$2.7M192.9k sharesSellJul 29, 2025$11.3K807 shares$14.00--
Mineralys Therapeutics, Inc.MLYS$2.7M193.7k sharesSellJul 28, 2025$181.8K12.9k shares$14.04--
Mineralys Therapeutics, Inc.MLYS$3.0M206.6k sharesSellJul 11, 2025$155.5K10.8k shares$14.45--
Mineralys Therapeutics, Inc.MLYS$2.6M215.3k sharesSellApr 11, 2025$129.7K10.8k shares$12.06--
Mineralys Therapeutics, Inc.MLYS$1.7M170k sharesGrant / ExerciseFeb 13, 2025$1.7M170k shares$10.20--
Mineralys Therapeutics, Inc.MLYS$2.2M226.1k sharesSellJan 13, 2025$963100 shares$9.63--
Mineralys Therapeutics, Inc.MLYS$2.1M226.2k sharesSellJan 13, 2025$96.9K10.7k shares$9.09--
Mineralys Therapeutics, Inc.MLYS$3.2M236.9k sharesSellOct 11, 2024$146.0K10.8k shares$13.57--
Mineralys Therapeutics, Inc.MLYS$3.3M247.6k sharesSellJul 11, 2024$141.4K10.8k shares$13.14--
Mineralys Therapeutics, Inc.MLYS$3.3M255.5k sharesSellJun 11, 2024$1.3M96.8k shares$12.94--